Beta ni Investment Corporation's globally first approved market listing of "youthful facial filler" for the temples.

Recently, the Bethenny Group has made substantial progress in the layout of the upstream industry chain in medical beauty. According to public information from the National Medical Products Administration, the "Injection Grade Poly-L-lactic Acid Filler" independently developed by Chengdu Yizhen Biotechnology Co., Ltd., a wholly-owned subsidiary of Yizheng Biotechnology Co., Ltd., in which Bethenny is an important strategic investor holding 15.73% equity, has recently obtained a Class III medical device registration certificate.